Anti-obesity drug market gaining traction in India : vimarsana.com

According to research firm Pharmarack, the market has tripled in two years after witnessing a sluggish growth till 2021. Over the last five years, the market has grown at 32% CAGR to 474 crore in January 2024.

Related Keywords

India , Sheetal Sapale , Anoop Misra , Centre Of Excellence , Novo Nordisk , Metabolic Diseases , Anti Obesity Drug , Weight Loss Drug , Obesity , Indian Pharma Sector , Fat Loss , Semaglutide ,